Cargando…
Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1)
Neurofibromatosis type 1 (NF1) is a genetic disorder that affects a range of tissue systems, however the associated muscle weakness and fatigability can have a profound impact on quality of life. Prior studies using the limb-specific Nf1 knockout mouse (Nf1(Prx1)(-/-)) revealed an accumulation of in...
Autores principales: | Vasiljevski, Emily R., Houweling, Peter J., Rupasinghe, Thusitha, Kaur, Tarneet, Summers, Matthew A., Roessner, Ute, Little, David G., Schindeler, Aaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446925/ https://www.ncbi.nlm.nih.gov/pubmed/32810864 http://dx.doi.org/10.1371/journal.pone.0237097 |
Ejemplares similares
-
L‐carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial
por: Vasiljevski, Emily R., et al.
Publicado: (2021) -
Skeletal muscle and motor deficits in Neurofibromatosis Type 1
por: Summers, M.A., et al.
Publicado: (2015) -
Correction: Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1)
Publicado: (2021) -
Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy
por: Davey, Christopher J., et al.
Publicado: (2021) -
Salt stress alters membrane lipid content and lipid biosynthesis pathways in the plasma membrane and tonoplast
por: Guo, Qi, et al.
Publicado: (2022)